Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP-5423P vs placebo in schizophrenia
CTR20160821Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Blonanserin transdermal patch in schizophrenia, sponsored by Sumitomo Pharma. Started Nov 2016; status: completed.
02
Drugs
Blonanserin transdermal patch
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20160821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160821.